Office Blood Pressure Changes and Control Transitions over Six Months in a Retrospective Hypertension Cohort

Background and Objectives: Mean blood pressure (BP) changes can conceal individual gains and losses of control. We described six-month office BP control transitions and recorded treatment-class changes, and explored the association between baseline adiponectin and six-month non-control with adjustment for kidney function. Materials and Methods: This retrospective secondary analysis included 125 adults with hypertension. Uncontrolled BP was defined as systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg. Paired analyses and control-state transitions used available follow-up data. Exploratory logistic models included age, baseline systolic BP, and sex, with additional adiponectin, estimated glomerular filtration rate (eGFR), and treatment sensitivity analyses. Multiplicity and selection-related optimism were examined. Results: Six-month BP was available for 91 participants. Control increased from 31/91 (34.1%) to 46/91 (50.5%; exact McNemar p = 0.020): 20 remained controlled, 26 achieved control, 11 lost control, and 34 remained uncontrolled. Mean paired systolic BP fell by 6.81 mmHg (95% confidence interval (CI) −11.47 to −2.16). Among 32 persistently uncontrolled participants with paired complete medication profiles, 4 had a net class-count increase. In 78 participants with adiponectin data, the adjusted odds ratio per doubling was 2.60 (95% CI 1.25–5.38); additional eGFR adjustment did not attenuate the estimate (2.70, 1.28–5.67). The univariable association did not survive false-discovery-rate correction (q = 0.094), and selection-inclusive internal validation did not establish stable incremental discrimination. Conclusions: Net improvement in office BP control coexisted with loss of control in 11/31 initially controlled attendees. Recorded class-count changes cannot establish therapeutic inertia or a programme effect. The adiponectin association remained exploratory after renal adjustment and does not support clinical testing or a prediction rule.

Authors

Institutions

Publication Details

Journal
Medicina
Published
2026-11-16
DOI
https://doi.org/10.3390/medicina62112239
Primary Topic
Blood Pressure and Hypertension Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Office Blood Pressure Changes and Control Transitions over Six Months in a Retrospective Hypertension Cohort

Ana-Maria Pah, Diana-Maria Mateescu, Dan Alexandru Surducan, Adina Cristiana Avram et al.
1 links
Medicina
Blood Pressure and Hypertension Studies
article

Office Blood Pressure Changes and Control Transitions over Six Months in a Retrospective Hypertension Cohort

Ana-Maria Pah, Diana-Maria Mateescu, Dan Alexandru Surducan, Adina Cristiana Avram, Maria Rada, Maria-Laura Craciun, Abdeldayem Mahmoud
article en

Abstract

Background and Objectives: Mean blood pressure (BP) changes can conceal individual gains and losses of control. We described six-month office BP control transitions and recorded treatment-class changes, and explored the association between baseline adiponectin and six-month non-control with adjustment for kidney function. Materials and Methods: This retrospective secondary analysis included 125 adults with hypertension. Uncontrolled BP was defined as systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg. Paired analyses and control-state transitions used available follow-up data. Exploratory logistic models included age, baseline systolic BP, and sex, with additional adiponectin, estimated glomerular filtration rate (eGFR), and treatment sensitivity analyses. Multiplicity and selection-related optimism were examined. Results: Six-month BP was available for 91 participants. Control increased from 31/91 (34.1%) to 46/91 (50.5%; exact McNemar p = 0.020): 20 remained controlled, 26 achieved control, 11 lost control, and 34 remained uncontrolled. Mean paired systolic BP fell by 6.81 mmHg (95% confidence interval (CI) −11.47 to −2.16). Among 32 persistently uncontrolled participants with paired complete medication profiles, 4 had a net class-count increase. In 78 participants with adiponectin data, the adjusted odds ratio per doubling was 2.60 (95% CI 1.25–5.38); additional eGFR adjustment did not attenuate the estimate (2.70, 1.28–5.67). The univariable association did not survive false-discovery-rate correction (q = 0.094), and selection-inclusive internal validation did not establish stable incremental discrimination. Conclusions: Net improvement in office BP control coexisted with loss of control in 11/31 initially controlled attendees. Recorded class-count changes cannot establish therapeutic inertia or a programme effect. The adiponectin association remained exploratory after renal adjustment and does not support clinical testing or a prediction rule.

MedicinaVol. 62(11)
Spitalul Clinic Judeţean de Urgenţă "Pius Brînzeu" Timişoara (RO), Victor Babeș University of Medicine and Pharmacy Timișoara (RO)
Good health and well-being
Blood Pressure and Hypertension Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon